| Brian Center Health And Rehabilitation/goldsboro | |
| 1700 Wayne Memorial Drive, Goldsboro, North Carolina 27534 | |
| (919) 731-2805 | |
| Name | Brian Center Health And Rehabilitation/goldsboro |
|---|---|
| Location | 1700 Wayne Memorial Drive, Goldsboro, North Carolina |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 130 |
| Occupancy Rate | 70.38% |
| Medicare ID (CCN) | 345343 |
| Legal Business Name | Ssc Goldsboro Operating Company Llc |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1487393088 |
| Organization Name | GOLDSBORO OPCO LLC |
| Address | 1700 Wayne Memorial Dr, Goldsboro, NC 27534 |
| Phone Number | 919-731-2805 |
News Archive
A survey of more than 1,000 U.S. adults has found that misperceptions about miscarriage and its causes are widespread. Results of the survey, conducted by researchers at Albert Einstein College of Medicine of Yeshiva University and Montefiore Health System, show that feelings of guilt and shame are common after a miscarriage and that most people erroneously believe that miscarriages are rare.
A study led by researchers at the University of North Carolina indicates that a newly approved blood thinner that blocks a key component of the human blood clotting system may increase the risk and severity of certain viral infections, including flu and myocarditis, a viral infection of the heart and a significant cause of sudden death in children and young adults.
With funding from the National Institutes of Health, University of Arkansas researchers hope to develop the first therapeutic drug that can regenerate heart tissue.
Delcath Systems, Inc., a medical technology company testing its proprietary treatment method for primary and metastatic cancers to the liver, announced that the U.S. Food & Drug Administration granted Delcath's request for orphan drug designation for doxorubicin for the treatment of hepatocellular carcinoma (HCC), also known as primary liver cancer. Clinicians in the U.S. diagnose nearly 20,000 cases of HCC annually.
› Verified 3 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
A survey of more than 1,000 U.S. adults has found that misperceptions about miscarriage and its causes are widespread. Results of the survey, conducted by researchers at Albert Einstein College of Medicine of Yeshiva University and Montefiore Health System, show that feelings of guilt and shame are common after a miscarriage and that most people erroneously believe that miscarriages are rare.
A study led by researchers at the University of North Carolina indicates that a newly approved blood thinner that blocks a key component of the human blood clotting system may increase the risk and severity of certain viral infections, including flu and myocarditis, a viral infection of the heart and a significant cause of sudden death in children and young adults.
With funding from the National Institutes of Health, University of Arkansas researchers hope to develop the first therapeutic drug that can regenerate heart tissue.
Delcath Systems, Inc., a medical technology company testing its proprietary treatment method for primary and metastatic cancers to the liver, announced that the U.S. Food & Drug Administration granted Delcath's request for orphan drug designation for doxorubicin for the treatment of hepatocellular carcinoma (HCC), also known as primary liver cancer. Clinicians in the U.S. diagnose nearly 20,000 cases of HCC annually.
› Verified 3 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 1 |
| Total Amount of Fines in Dollars | $46176 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 1 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 13.33 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 11.87 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 69.09 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 0 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 1.73 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 3.77 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 1.16 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 84.5 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 3.98 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 98.85 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 0.74 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 21.12 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 11.79 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 17.43 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 98.26 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 84.59 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 98.18 | 82.93 |
News Archive
A survey of more than 1,000 U.S. adults has found that misperceptions about miscarriage and its causes are widespread. Results of the survey, conducted by researchers at Albert Einstein College of Medicine of Yeshiva University and Montefiore Health System, show that feelings of guilt and shame are common after a miscarriage and that most people erroneously believe that miscarriages are rare.
A study led by researchers at the University of North Carolina indicates that a newly approved blood thinner that blocks a key component of the human blood clotting system may increase the risk and severity of certain viral infections, including flu and myocarditis, a viral infection of the heart and a significant cause of sudden death in children and young adults.
With funding from the National Institutes of Health, University of Arkansas researchers hope to develop the first therapeutic drug that can regenerate heart tissue.
Delcath Systems, Inc., a medical technology company testing its proprietary treatment method for primary and metastatic cancers to the liver, announced that the U.S. Food & Drug Administration granted Delcath's request for orphan drug designation for doxorubicin for the treatment of hepatocellular carcinoma (HCC), also known as primary liver cancer. Clinicians in the U.S. diagnose nearly 20,000 cases of HCC annually.
› Verified 3 days ago
Willow Creek Nursing And Rehabilitation Center Location: 2401 Wayne Memorial Drive, Goldsboro, North Carolina 27534 Phone: (919) 736-2121 | |
Brian Center Health And Rehabilitation/goldsboro Location: 1700 Wayne Memorial Drive, Goldsboro, North Carolina 27534 Phone: (919) 731-2805 | |
O'berry Neuro-medical Treatment Center Location: 400 Old Smithfield Road, Goldsboro, North Carolina 27533 Phone: (919) 581-4015 |